Biochemical properties of liver megamitochondria induced by chloramphenicol or cuprizone.
D000284:Administration, Oral; D000818:Animals; D002701:Chloramphenicol / Q000494:pharmacology*; D003471:Cuprizone / Q000494:pharmacology*; D003510:Cyclohexanes / Q000494:pharmacology*; D003513:Cycloheximide / Q000494:pharmacology; D003580:Cytochromes / Q000378:metabolism; D004032:Diet; D003576:Electron Transport Complex IV / Q000378:metabolism; D008297:Male; D051379:Mice; D008930:Mitochondria, Liver / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D009251:NADPH-Ferrihemoprotein Reductase / Q000378:metabolism; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010743:Phospholipids / Q000096:biosynthesis; D014176:Protein Biosynthesis; D011808:Quinone Reductases / Q000378:metabolism; D014451:Ubiquinone / Q000378:metabolism
D003510:Cyclohexanes; D003580:Cytochromes; D010743:Phospholipids; D014451:Ubiquinone; D003471:Cuprizone; D002701:Chloramphenicol; D003513:Cycloheximide; D009251:NADPH-Ferrihemoprotein Reductase; D011808:Quinone Reductases; D003576:Electron Transport Complex IV